FDA says it has responded to a Universities Allied for Essential Medicines by creating a dashboard of Clinical Trials.gov pre-notice letters on potent...
FDA clears a ClearPoint Neuro 510(k) for use of its ClearPoint 2.2 software with the integrated Maestro Brain Modeling.
FDA clears a Zimmer Biomet 510(k) for the ROSA Shoulder System for robotic-assisted shoulder replacement surgery.
Industry stakeholders question the usefulness and design of proposed CDER Office of Prescription Drug Promotion research into implied claims in direct...
The CDER Office of Generic Drugs 2023 annual report details the 956 ANDAs approved or tentatively approved last year.
Two Hogan Lovells attorneys and two Greenleaf Health executives discuss FDA actions in this election year at a recent J.P. Morgan healthcare conferenc...
FDA grants Better Therapeutics a breakthrough device designation for its Cognitive Behavioral Therapy platform that is intended to treat adults with m...
Federal Register notice: FDA makes available a final guidance entitled Assessing Covid19-Related Symptoms in Outpatient Adult and Adolescent Subjects ...